Bactericidal/permeability-increasing protein—Lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia
2001 ◽
Vol 29
◽
pp. S130-S135
◽
Keyword(s):